Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation Recalls

All product recalls associated with Novartis Pharmaceuticals Corporation.

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Nov 2023

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–6 of 6 recalls

SANDIMMUNE Oral Solution (Novartis) – Crystallization Risk (2023)

Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals

Class IHigh

FDANov 22, 2023Nationwide• Novartis Pharmaceuticals Corporation

Neoral Cyclosporine Capsules (Novartis) – Ethanol Content Issue (2022)

CGMP deviations: Out of specification results obtained during routine stability testing for ethanol content.

Class IIModerate

FDASep 16, 2022Nationwide• Novartis Pharmaceuticals Corporation

Xiidra Professional Sample (Novartis) - Impurity Specifications (2022)

Failed Impurities/Degradation Specifications.

Class III

Low

FDAMay 10, 2022Nationwide• Novartis Pharmaceuticals Corporation

Xiidra (Novartis) - Impurity Specifications (2022)

Failed Impurities/Degradation Specifications.

Class IIILow

FDAMay 10, 2022Nationwide• Novartis Pharmaceuticals Corporation

Xiidra (Novartis) - Impurity Specifications (2022)

Failed Impurities/Degradation Specifications.

Class IIILow

FDAMay 10, 2022Nationwide• Novartis Pharmaceuticals Corporation

Xiidra Professional Sample (Novartis) - Impurity Specifications (2022)

Failed Impurities/Degradation Specifications.

Class IIILow

FDAMay 10, 2022Nationwide• Novartis Pharmaceuticals Corporation